Inventor · disambiguated record
Fenggen Fu
Also filed as: FU FENGGEN
1 granted patent·9 pending applications·1 citations·filing 2019–2022
17Inventor score
Files withINNOVENT BIOLOGICS SUZHOU CO LTD8FORTVITA BIOLOGICS SINGAPORE PTE LTD1INNOVENT BIOLOGICS SINGAPORE PTE LTD1
Top patents by PatentIndex Score
10 records- 0170US12269855B2Interleukin-2 and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2019·Granted Apr 8, 2025·1 cites·12 claims
- 0258US2024391973A1Interleukin-2 mutant and fusion protein thereofFORTVITA BIOLOGICS SINGAPORE PTE LTD·Filed 2022·Application pending·0 cites
- 0350US2024239881A1Anti-ang-2 antibody and its usageINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0448US2023374132A1Anti-cd3 antibody and uses thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0546US2024228579A1Fc mutant with altered binding to fc receptorINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 0646US2023174604A1Interleukin-2 mutant and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0745US2024043540A1Anti-b7-h3 antibody and uses thereofINNOVENT BIOLOGICS SINGAPORE PTE LTD·Filed 2021·Application pending·0 cites
- 0845US2024034795A1Protein containing heterodimer antibody fc, and preparation method thereforINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0944US2024043487A1Interleukin-21 mutant and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 1043US2023145766A1Interleukin-2 mutant and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fenggen Fu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →